# Alpha-1 Blockade for Alcohol Use Disorder (AUD)

> **NCT04135846** · PHASE2 · RECRUITING · sponsor: **Brown University** · enrollment: 184 (estimated)

## Conditions studied

- Alcohol Use Disorder (AUD)

## Interventions

- **DRUG:** Doxazosin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04135846
- **Lead sponsor:** Brown University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-12-19
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 184 (ESTIMATED)
- **Last updated:** 2026-03-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04135846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04135846, "Alpha-1 Blockade for Alcohol Use Disorder (AUD)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04135846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*